| HOME >> MEDICINE >> TECHNOLOGY |
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
A Quick Primer II-1
Current and Future Analysis II-1
United States - The Largest Market for IV Iron Drugs II-1
Europe and Rest of World - High Potential Markets II-2
Noteworthy Trends in the IV Iron Drug Market II-2
No Impact of Recession on Intravenous Iron Market II-2
Dialysis Clinics are Major Clients for IV Iron Supplements II-2
Global Iron Supplement Market II-2
Table 1: Global Intravenous (IV) Iron Market (2006):
Percentage Breakdown of Value Sales for Intravenous Iron Drug
Type - Non Generics and Generics II-3
Table 2: Leading Players in the Global Intravenous (IV) Iron
Market (2006): Percentage Breakdown of Value Sales for Vifor,
Sanofi-Aventis, Pharmacosmos, and Others (including Generics)
(includes corresponding Graph/Chart) II-3
Vifor Pharma - Dominates IV Iron Drugs Market II-3
2. OVERVIEW OF INTRAVENOUS (IV) IRON DRUGS II-4
Significance of Iron in Human Body II-4
Intravenous Therapy II-4
Iron-Deficiency Anemia II-4
People with High Susceptibility to Anemia II-4
Older Adults & the Elderly II-5
Cancer Patients II-5
Women of Child-bearing Age II-5
Chronic Kidney Disease Patients II-5
HIV/AIDS Patients II-5
People with Inflammatory Bowel Disease II-5
Diabetics II-6
People with Heart Disease II-6
Critically Ill Patients II-6
Infants II-6
People with Other Diseases II-6
Table 3: Intravenous (IV) Iron Drugs Market (2009):
Prevalence of Iron Deficiency Disease (IDA) by Risk Groups-
Pregnant Women, Children (1-2 years), Women (12-49
years), Women (50+ years), and Men (12+ years) (includes
corresponding Graph/Chart) II-6
Treatment for Iron Deficiency Anemia II-7
Iron Re
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |